Archives

Keynote Speaker Anna Abram

2018 AAADV Keynote Speaker Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis with Richard Pazdur, M.D., Director of FDA Oncology Center of Excellence.

2018 AAADV Schedule

Click Here – 2019 AAADV Workshop Schedule Wednesday May 2, 2018 Thursday may 3, 2018 Friday May 4, 2018 Wednesday May 2, 2018 08:00 AM – 09:30 AM | Registration/Continental Breakfast 08:30 AM – 12:00 PM | Core CurriculumDrug Development for Early Career Investigators MODERATORTatiana Prowell, M.D. | Early Efficacy Trials, Biomarkers, and Diagnostic Tests SPEAKERTatiana […]

2017 AAADV Schedule

Wednesday May 3, 2017 Thursday May 4, 2017 Friday May 5, 2017 Wednesday May 3, 2017 08:00 AMIntroductions and OverviewH. Kim Lyerly, M.D.AAADV Chair 08:15 AMPlenary Session IA Systems Biology Approach to Cancer Drug Discovery and Development: Master Regulators as Drug TargetsModerator :Gregory Reaman, M.D.; U.S. Food and Drug AdministrationA Systems Biology Approach to Cancer […]

2016 AAADV Workshop

Palo Alto, CA Fundamentals and Scholars Panel at #aaadv2016 on #bigdata includes @US_FDA @flatironhealth. Intro: “Big data is just a transition point.”

AAADV Workshop 2016, Julie Bullock

Director of Clinical Pharmacology for d3 Medicine and Workshop planning committee member Julie Bullock explains how the unusual opportunity to interact informally with FDA officials involved in the drug approval process is an important opportunity for AAADV Workshop participants.

AAADV Workshop 2016, Tatiana Prowell

AAADV Workshop Published by Lori Wile · May 4 at 12:53pm · .. U.S. FDA’s Breast Cancer Scientific Lead and Workshop planning committee member Tatiana Prowell talks about AAADV’s goals and purpose at opening day of the 2016 Workshop.

AAADV LOGO